Key Findings
- Across 16 RCTs (2,147 participants), berberine was associated with reduced total cholesterol (mean difference −0.47 mmol/L), LDL cholesterol (−0.38 mmol/L), and triglycerides (−0.28 mmol/L).
- HDL cholesterol rose modestly when berberine was used on its own (+0.08 mmol/L).
- The methodological quality of many included trials was limited, which lowers certainty.
- Berberine affects drug-metabolizing enzymes (CYP3A4) and transporters, so it can change the levels of many medications.